Aquis listed ProBiotix Health is a life sciences company that develops probiotic formulations to support cardiometabolic health. Since its creation, ProBiotix has become a global leader in microbiome modulating probiotics for use in food supplements and nutraceuticals.

At the heart of the Company’s mission lies a unique approach; discovering groundbreaking probiotics, ensuring their benefits through solid science, and bringing to market effective finished probiotic-based products for human health across the globe.

ProBiotix are dedicated to being at the forefront of advancing global health through nature’s own mechanisms. The Company’s probiotic solutions harness the power of beneficial bacteria to promote wellness from the inside out.

Using cutting-edge research to develop innovative probiotic solutions, ProBiotix aims to tackle lifestyle conditions such as cardiometabolic health.The ProBiotix commitment to ongoing technology, research and scientific development ensures you’ll always stay ahead in the probiotic field. Identification – Validation – Commercialisation.

The Company has published multiple clinical trials with leading UK universities and world-leading professors in microbiology to support the efficacy and safety of our products, and will continue to do so.

ProBiotix Health is a subsidiary of AIM listed OptiBiotix. OptiBiotix was formed in March 2012 by Stephen O’Hara, the Company’s Chief Executive, to develop compounds which modify the human microbiome to prevent and manage human disease. On 31 March 2022, ProBiotix Health acquired ProBiotix in a share for share exchange.

Link here to the ProBiotix Health website

[catlist name=”ProBiotix Health (PBX)” numberposts=150]